euroAtlantic Airways Grows With Its First A330-200 Aircraft
24.7.2025 09:00:00 CEST | Business Wire | Press Release
euroAtlantic Airways (“EAA”), is pleased to announce the addition of the CS-TGD, its first Airbus A330-200, to its fleet, marking a significant milestone in the Company's expansion and commitment to providing exceptional services to its clients.
The A330-200, which is leased from AELF, is the sixth widebody aircraft in EAA’s fleet, and the Company’s first ever Airbus aircraft in its >30-year history. Powered by General Electric CF6-80E engines, the aircraft delivers reliable performance and fuel efficiency while supporting a maximum takeoff weight of 233,000 kg, ensuring optimal payload capacity for long-haul operations. Today, it is configured with 12 Business Class seats and 283 Economy Class seats, accommodating 295 passengers in total.
EAA is currently operating for LOT Polish Airlines on its daily New York to Warsaw route and for Azul on Lisbon to Campinas, Porto to Recife, and Madrid. The leading ACMI business also provides services for government entities, including the United Nations.
Stewart Higginson, CEO and Chairman of euroAtlantic Airways, commented: "We are excited to welcome the A330-200 to our fleet. The addition represents the next stage in EAA's journey towards enhancing its operational capabilities and market presence. Recognised for its operational efficiency and superior passenger experience, this aircraft represents a significant milestone for euroAtlantic, marking our transition to a dual Boeing and Airbus operator. It further expands our long-haul product offering for the charter and ACMI market segments. We are grateful to AELF for their support and collaboration and look forward to partnering with leading airlines to provide best in class customer experience."
Joe Cirillo, Chief Commercial Officer of AELF, added: “We are proud to partner with EAA on the lease of this A330-200 and support their ambitious fleet development. We specialise in providing tailored, flexible leasing solutions to dynamic operators like EAA, who are expanding their footprint in key global markets. We look forward to supporting EAA as they continue to grow and innovate in the ACMI and charter sectors."
About euroAtlantic Airways
euroAtlantic Airways is a Portuguese airline specializing in ACMI and charter solutions, operating a diverse fleet of aircraft. Headquartered in Carnaxide and based at Lisbon Airport, it offers wet-lease, charter services, and Ad-Hoc flights across the globe, and has served 727 Airports in 167 countries in 32 years of operations. With over three decades of expertise in the aviation industry, EAA has established itself as a global leader in providing ACMI (Aircraft, Crew, Maintenance, and Insurance) and Charter solutions. Over the years, the Company has earned a reputation for delivering tailored services that meet the unique needs of its clients, with a continued focus on safety, efficiency, and innovation. Since 2024, euroAtlantic Airways is majority owned by Njord Partners.
To find out more visit: https://www.euroatlantic.pt/en/quem-somos/
About AELF
Aircraft Engine Lease Finance Inc. (“AELF”) is an experienced commercial aircraft lessor. Based in Chicago, AELF offers customized and flexible financing solutions to airlines and commercial aircraft operators worldwide. AELF has been in operation for a decade and is continually expanding its commercial aircraft and engine portfolio. Learn more at www.aelfinc.com.
To find out more visit: https://www.aelfinc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250724081597/en/
Contacts
Media enquiries: via Camarco
Jennifer Renwick
Letaba Rimell
njord@apcoworldwide.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press Release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
Digital Reef Turns to Vertical Farming to Reduce Data Centre Footprint in Partnership With Elevate Farms and Xange.com to Provide Digital Measurement, Reporting and Verification of Project's Environmental Impact Within the Reef Origin Ecosystem23.10.2026 13:12:00 CEST | Press Release
Elevate Farms Inc. and Digital Reef Ltd partnership supports mitigating environmental impact of global data centre expansion establishing a framework for Digital Reef’s infrastructure pipeline to support and utilize environmental assets generated by Elevate Farms' high-yield, closed-loop vertical farming operations. Traditional agriculture supply chains are replaced with optimized indoor facilities significantly reducing food production carbon emissions, water waste and local land constraints. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022393352/en/ Elevate Farms technology offers part of the solution to climate impact isolating food production from traditional agricultural farming variables saving over 95% of standard water requirements and significantly reducing farmland required for equivalent yields and logistical carbon. Digital Reef CEO Piers Slater stated "Digital Reef embrace data centre growth and environment
SLB Announces Third-Quarter 2026 Results23.10.2026 12:50:00 CEST | Press Release
SLB (NYSE: SLB) today announced results for the third-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261021694458/en/ The exterior of the SLB headquarters in Houston, Texas. Third-Quarter Results (Stated in millions, except per share amounts)Three Months EndedChangeSept. 30, 2026Jun. 30, 2026Sept. 30, 2025SequentialYear-on-yearRevenue $9,449 $8,972 $8,928 5% 6% Income before taxes - GAAP basis $1,019 $1,018 $1,000 0% 2% Income before taxes margin - GAAP basis 10.8% 11.4% 11.2% -57 bps -42 bps Net income attributable to SLB - GAAP basis $735 $786 $739 -6% -1% Diluted EPS - GAAP basis $0.49 $0.52 $0.50 -6% -2% Adjusted EBITDA* $2,067 $1,899 $2,061 9% - Adjusted EBITDA margin* 21.9% 21.2% 23.1% 71 bps -121 bps Pretax segment operating income* $1,576 $1,404 $1,626 12% -3% Pretax segment operating margin* 16.7% 15.6% 18.2% 104 bps -153 bps Net income attributable to SLB, excluding charges & credits* $962 $833 $1,027
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom